{
    "2020-05-22": [
        [
            {
                "time": "",
                "original_text": "A股公司加速引进战投，产业联动、资源储备成亮点",
                "features": {
                    "keywords": [
                        "A股",
                        "战投",
                        "产业联动",
                        "资源储备"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "投资"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "生物医药行业新冠疫苗研发系列报告2：灭活疫苗技术在COVID-19疫苗研发中的应用及进展",
                "features": {
                    "keywords": [
                        "生物医药",
                        "新冠疫苗",
                        "灭活疫苗",
                        "技术研发"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "5月",
                "original_text": "5月国内药企再现离职潮，不乏上市药企和知名高管",
                "features": {
                    "keywords": [
                        "药企",
                        "离职潮",
                        "高管变动"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物扣非净利三年增87倍 蒋仁生财富一年半涨371亿",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "扣非净利",
                        "增长",
                        "蒋仁生",
                        "财富"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}